Cdks, cyclins and CKIs: Roles beyond cell cycle regulation

Development (Cambridge)

Volumn 140, Issue 15, 2013, Pages 3079-3093

  Lim, Shuhui ^a   Kaldis, Philipp ^a,b  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cdk; Cki; Cyclin; Dna damage repair; Epigenetic regulation; Metabolism; Neuronal functions; Proteolytic degradation; Spermatogenesis; Stem cell self renewal; Transcription

Indexed keywords

CYCLIN A; CYCLIN B; CYCLIN C; CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 10; CYCLIN DEPENDENT KINASE 11; CYCLIN DEPENDENT KINASE 12; CYCLIN DEPENDENT KINASE 13; CYCLIN DEPENDENT KINASE 14; CYCLIN DEPENDENT KINASE 15; CYCLIN DEPENDENT KINASE 16; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE 7; CYCLIN DEPENDENT KINASE 8; CYCLIN DEPENDENT KINASE 9; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; CYCLIN F; CYCLIN H; CYCLIN K; CYCLIN L; CYCLIN T; CYCLIN Y; CYCLINE; UNCLASSIFIED DRUG;

BINDING SITE; CATALYSIS; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL METABOLISM; CELL RENEWAL; COMPLEX FORMATION; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPIGENETICS; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; NERVE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVIEW; SPERMATOGENESIS; STEM CELL;

CDK; CKI; CYCLIN; DNA DAMAGE REPAIR; EPIGENETIC REGULATION; METABOLISM; NEURONAL FUNCTIONS; PROTEOLYTIC DEGRADATION; SPERMATOGENESIS; STEM CELL SELF-RENEWAL; TRANSCRIPTION;

AMINO ACID SEQUENCE; ANIMALS; CELL CYCLE CHECKPOINTS; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA REPAIR; EPIGENESIS, GENETIC; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEURONS; PROTEOLYSIS; SPERMATOGENESIS; STEM CELLS; TRANSCRIPTION, GENETIC;

EID: 84880264045     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.091744     Document Type: Review

References (141)

1. Adkins, J. N. and Lumb, K. J. (2002). Intrinsic structural disorder and sequence features of the cell cycle inhibitor p57Kip2. Proteins 46, 1-7.
2. Aggarwal, P., Vaites, L. P., Kim, J. K., Mellert, H., Gurung, B., Nakagawa, H., Herlyn, M., Hua, X., Rustgi, A. K., McMahon, S. B. et al. (2010). Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase. Cancer Cell 18, 329-340.
3. Akoulitchev, S., Chuikov, S. and Reinberg, D. (2000). TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature 407, 102-106.
4. Ali, F., Hindley, C., McDowell, G., Deibler, R., Jones, A., Kirschner, M., Guillemot, F. and Philpott, A. (2011). Cell cycle-regulated multi-site phosphorylation of Neurogenin 2 coordinates cell cycling with differentiation during neurogenesis. Development 138, 4267-4277.
5. Alvarez-Fernandez, M., Halim, V. A., Aprelia, M., Laoukili, J., Mohammed, S. and Medema, R. H. (2011). Protein phosphatase 2A (B55α) prevents premature activation of forkhead transcription factor FoxM1 by antagonizing cyclin A/cyclin-dependent kinase-mediated phosphorylation. J. Biol. Chem. 286, 33029-33036.
6. Anastas, J. N. and Moon, R. T. (2013). WNT signalling pathways as therapeutic targets in cancer. Nat. Rev. Cancer 13, 11-26.
7. Atherton-Fessler, S., Parker, L. L., Geahlen, R. L. and Piwnica-Worms, H. (1993). Mechanisms of p34cdc2 regulation. Mol. Cell. Biol. 13, 1675-1685.
8. Bagella, L., Giacinti, C., Simone, C. and Giordano, A. (2006). Identification of murine cdk10: association with Ets2 transcription factor and effects on the cell cycle. J. Cell. Biochem. 99, 978-985.
9. Bartkowiak, B., Liu, P., Phatnani, H. P., Fuda, N. J., Cooper, J. J., Price, D. H., Adelman, K., Lis, J. T. and Greenleaf, A. L. (2010). CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. Genes Dev. 24, 2303-2316.
10. Bassermann, F., Eichner, R. and Pagano, M. (2013). The ubiquitin proteasome system-Implications for cell cycle control and the targeted treatment of cancer. Biochim. Biophys. Acta. (in press)
11. Beach, D., Durkacz, B. and Nurse, P. (1982). Functionally homologous cell cycle control genes in budding and fission yeast. Nature 300, 706-709.
12. Becker, K. A., Ghule, P. N., Therrien, J. A., Lian, J. B., Stein, J. L., van Wijnen, A. J. and Stein, G. S. (2006). Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. J. Cell. Physiol. 209, 883-893.
13. Bell, D., Berchuck, A., Birrer, M., Chien, J., Cramer, D. W., Dao, F., Dhir, R., DiSaia, P., Gabra, H., Glenn, P. et al.; Cancer Genome Atlas Research Network (2011). Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615.
14. Berthet, C., Aleem, E., Coppola, V., Tessarollo, L. and Kaldis, P. (2003). Cdk2 knockout mice are viable. Curr. Biol. 13, 1775-1785.
15. Besset, V., Rhee, K. and Wolgemuth, D. J. (1999). The cellular distribution and kinase activity of the Cdk family member Pctaire1 in the adult mouse brain and testis suggest functions in differentiation. Cell Growth Differ. 10, 173-181.
16. Besson, A., Dowdy, S. F. and Roberts, J. M. (2008). CDK inhibitors: cell cycle regulators and beyond. Dev. Cell 14, 159-169.
17. Bienvenu, F., Jirawatnotai, S., Elias, J. E., Meyer, C. A., Mizeracka, K., Marson, A., Frampton, G. M., Cole, M. F., Odom, D. T., Odajima, J. et al. (2010). Transcriptional role of cyclin D1 in development revealed by a geneticproteomic screen. Nature 463, 374-378.
18. Bienz, M. and Clevers, H. (2000). Linking colorectal cancer to Wnt signaling. Cell 103, 311-320.
19. Blazek, D., Kohoutek, J., Bartholomeeusen, K., Johansen, E., Hulinkova, P., Luo, Z., Cimermancic, P., Ule, J. and Peterlin, B. M. (2011). The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. Genes Dev. 25, 2158-2172.
20. Brambilla, R. and Draetta, G. (1994). Molecular cloning of PISSLRE, a novel putative member of the cdk family of protein serine/threonine kinases. Oncogene 9, 3037-3041.
21. Burdon, T., Smith, A. and Savatier, P. (2002). Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol. 12, 432-438.
22. Calegari, F. and Huttner, W. B. (2003). An inhibition of cyclin-dependent kinases that lengthens, but does not arrest, neuroepithelial cell cycle induces premature neurogenesis. J. Cell Sci. 116, 4947-4955.
23. Chen, Y. J., Dominguez-Brauer, C., Wang, Z., Asara, J. M., Costa, R. H., Tyner, A. L., Lau, L. F. and Raychaudhuri, P. (2009). A conserved phosphorylation site within the forkhead domain of FoxM1B is required for its activation by cyclin-CDK1. J. Biol. Chem. 284, 30695-30707.
24. Chen, S., Bohrer, L. R., Rai, A. N., Pan, Y., Gan, L., Zhou, X., Bagchi, A., Simon, J. A. and Huang, H. (2010). Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nat. Cell Biol. 12, 1108-1114.
25. Chen, X., Niu, H., Chung, W. H., Zhu, Z., Papusha, A., Shim, E. Y., Lee, S. E., Sung, P. and Ira, G. (2011). Cell cycle regulation of DNA double-strand break end resection by Cdk1-dependent Dna2 phosphorylation. Nat. Struct. Mol. Biol. 18, 1015-1019.
26. Cheng, S. W., Kuzyk, M. A., Moradian, A., Ichu, T. A., Chang, V. C., Tien, J. F., Vollett, S. E., Griffith, M., Marra, M. A. and Morin, G. B. (2012). Interaction of cyclin-dependent kinase 12/CrkRS with cyclin K1 is required for the phosphorylation of the C-terminal domain of RNA polymerase II. Mol. Cell. Biol. 32, 4691-4704.
27. Cisek, L. J. and Corden, J. L. (1989). Phosphorylation of RNA polymerase by the murine homologue of the cell-cycle control protein cdc2. Nature 339, 679-684.
28. Coqueret, O. (2002). Linking cyclins to transcriptional control. Gene 299, 35-55.
29. D'Angiolella, V., Donato, V., Vijayakumar, S., Saraf, A., Florens, L., Washburn, M. P., Dynlacht, B. and Pagano, M. (2010). SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation. Nature 466, 138-142.
30. D'Angiolella, V., Donato, V., Forrester, F. M., Jeong, Y. T., Pellacani, C., Kudo, Y., Saraf, A., Florens, L., Washburn, M. P. and Pagano, M. (2012). Cyclin Fmediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair. Cell 149, 1023-1034.
31. D'Angiolella, V., Esencay, M. and Pagano, M. (2013). A cyclin without cyclindependent kinases: cyclin F controls genome stability through ubiquitinmediated proteolysis. Trends Cell Biol. 23, 135-140.
32. Davidson, G. and Niehrs, C. (2010). Emerging links between CDK cell cycle regulators and Wnt signaling. Trends Cell Biol. 20, 453-460.
33. Davidson, G., Shen, J., Huang, Y. L., Su, Y., Karaulanov, E., Bartscherer, K., Hassler, C., Stannek, P., Boutros, M. and Niehrs, C. (2009). Cell cycle control of wnt receptor activation. Dev. Cell 17, 788-799.
34. Dehay, C. and Kennedy, H. (2007). Cell-cycle control and cortical development. Nat. Rev. Neurosci. 8, 438-450.
35. Delavaine, L. and La Thangue, N. B. (1999). Control of E2F activity by p21Waf1/Cip1. Oncogene 18, 5381-5392.
36. Devgan, V., Mammucari, C., Millar, S. E., Brisken, C. and Dotto, G. P. (2005). p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes Dev. 19, 1485-1495.
37. Dickinson, L. A., Edgar, A. J., Ehley, J. and Gottesfeld, J. M. (2002). Cyclin L is an RS domain protein involved in pre-mRNA splicing. J. Biol. Chem. 277, 25465-25473.
38. Dimri, G. P., Nakanishi, M., Desprez, P. Y., Smith, J. R. and Campisi, J. (1996). Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol. Cell. Biol. 16, 2987-2997.
39. Dotto, G. P. (2000). p21(WAF1/Cip1): more than a break to the cell cycle? Biochim. Biophys. Acta 1471, M43-M56.
40. Dyson, N. (1998). The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245-2262.
41. Esteve, V., Canela, N., Rodriguez-Vilarrupla, A., Aligue, R., Agell, N., Mingarro, I., Bachs, O. and Perez-Paya, E. (2003). The structural plasticity of the C terminus of p21Cip1 is a determinant for target protein recognition. Chem. Biochem. 4, 863-869.
42. Evans, T., Rosenthal, E. T., Youngblom, J., Distel, D. and Hunt, T. (1983). Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell 33, 389-396.
43. Fantl, V., Stamp, G., Andrews, A., Rosewell, I. and Dickson, C. (1995). Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9, 2364-2372.
44. Firestein, R., Bass, A. J., Kim, S. Y., Dunn, I. F., Silver, S. J., Guney, I., Freed, E., Ligon, A. H., Vena, N., Ogino, S. et al. (2008). CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 455, 547-551.
45. Fu, T.-J., Peng, J., Lee, G., Price, D. H. and Flores, O. (1999). Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription. J. Biol. Chem. 274, 34527-34530.
46. Ganuza, M., Saiz-Ladera, C., Canamero, M., Gomez, G., Schneider, R., Blasco, M. A., Pisano, D., Paramio, J. M., Santamaria, D. and Barbacid, M. (2012). Genetic inactivation of Cdk7 leads to cell cycle arrest and induces premature aging due to adult stem cell exhaustion. EMBO J. 31, 2498-2510.
47. Geng, Y., Lee, Y. M., Welcker, M., Swanger, J., Zagozdzon, A., Winer, J. D., Roberts, J. M., Kaldis, P., Clurman, B. E. and Sicinski, P. (2007). Kinaseindependent function of cyclin E. Mol. Cell 25, 127-139.
48. Gopinathan, L., Ratnacaram, C. K. and Kaldis, P. (2011). Established and novel Cdk/cyclin complexes regulating the cell cycle and development. Results Probl. Cell Differ. 53, 365-389.
49. Gotz, M. and Huttner, W. B. (2005). The cell biology of neurogenesis. Nat. Rev. Mol. Cell Biol. 6, 777-788.
50. Grana, X., Claudio, P. P., De Luca, A., Sang, N. and Giordano, A. (1994). PISSLRE, a human novel CDC2-related protein kinase. Oncogene 9, 2097-2103.
51. Hannenhalli, S. and Kaestner, K. H. (2009). The evolution of Fox genes and their role in development and disease. Nat. Rev. Genet. 10, 233-240.
52. Hanse, E. A., Mashek, D. G., Becker, J. R., Solmonson, A. D., Mullany, L. K., Mashek, M. T., Towle, H. C., Chau, A. T. and Albrecht, J. H. (2012). Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α. Cell Cycle 11, 2681-2690.
53. Harbour, J. W. and Dean, D. C. (2000). The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14, 2393-2409.
54. Hengartner, C. J., Myer, V. E., Liao, S.-M., Wilson, C. J., Koh, S. S. and Young, R. A. (1998). Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases. Mol. Cell 2, 43-53.
55. Herrup, K. and Yang, Y. (2007). Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat. Rev. Neurosci. 8, 368-378.
56. Hindley, C. and Philpott, A. (2012). Co-ordination of cell cycle and differentiation in the developing nervous system. Biochem. J. 444, 375-382.
57. Holmes, J. K. and Solomon, M. J. (1996). A predictive scale for evaluating cyclin-dependent kinase substrates. A comparison of p34cdc2 and p33cdk2. J. Biol. Chem. 271, 25240-25246.
58. Hu, D. L., Mayeda, A., Trembley, J. H., Lahti, J. M. and Kidd, V. J. (2003). CDK11 complexes promote pre-mRNA splicing. J. Biol. Chem. 278, 8623-8629.
59. Hu, M. G., Deshpande, A., Enos, M., Mao, D., Hinds, E. A., Hu, G. F., Chang, R., Guo, Z., Dose, M., Mao, C. et al. (2009). A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis. Cancer Res. 69, 810-818.
60. Huang, E., Qu, D., Zhang, Y., Venderova, K., Haque, M. E., Rousseaux, M. W., Slack, R. S., Woulfe, J. M. and Park, D. S. (2010). The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death. Nat. Cell Biol. 12, 563-571.
61. Huertas, P., Cortes-Ledesma, F., Sartori, A. A., Aguilera, A. and Jackson, S. P. (2008). CDK targets Sae2 to control DNA-end resection and homologous recombination. Nature 455, 689-692.
62. Iorns, E., Turner, N. C., Elliott, R., Syed, N., Garrone, O., Gasco, M., Tutt, A. N., Crook, T., Lord, C. J. and Ashworth, A. (2008). Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer. Cancer Cell 13, 91-104.
63. Jiang, M., Gao, Y., Yang, T., Zhu, X. and Chen, J. (2009). Cyclin Y, a novel membrane-associated cyclin, interacts with PFTK1. FEBS Lett. 583, 2171-2178.
64. Jirawatnotai, S., Hu, Y., Michowski, W., Elias, J. E., Becks, L., Bienvenu, F., Zagozdzon, A., Goswami, T., Wang, Y. E., Clark, A. B. et al. (2011). A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. Nature 474, 230-234.
65. Kaldis, P. and Pagano, M. (2009). Wnt signaling in mitosis. Dev. Cell 17, 749-750.
66. Kaneko, S., Li, G., Son, J., Xu, C. F., Margueron, R., Neubert, T. A. and Reinberg, D. (2010). Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev. 24, 2615-2620.
67. Kasten, M. and Giordano, A. (2001). Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity. Oncogene 20, 1832-1838.
68. Knuesel, M. T., Meyer, K. D., Bernecky, C. and Taatjes, D. J. (2009). The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function. Genes Dev. 23, 439-451.
69. Kohoutek, J., Li, Q., Blazek, D., Luo, Z., Jiang, H. and Peterlin, B. M. (2009). Cyclin T2 is essential for mouse embryogenesis. Mol. Cell. Biol. 29, 3280-3285.
70. Lacy, E. R., Filippov, I., Lewis, W. S., Otieno, S., Xiao, L., Weiss, S., Hengst, L. and Kriwacki, R. W. (2004). p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding. Nat. Struct. Mol. Biol. 11, 358-364.
71. Laoukili, J., Kooistra, M. R. H., Bras, A., Kauw, J., Kerkhoven, R. M., Morrison, A., Clevers, H. and Medema, R. H. (2005). FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat. Cell Biol. 7, 126-136.
72. Laoukili, J., Alvarez, M., Meijer, L. A., Stahl, M., Mohammed, S., Kleij, L., Heck, A. J. and Medema, R. H. (2008). Activation of FoxM1 during G2 requires cyclin A/Cdk-dependent relief of autorepression by the FoxM1 N-terminal domain. Mol. Cell. Biol. 28, 3076-3087.
73. Lavoie, G. and St-Pierre, Y. (2011). Phosphorylation of human DNMT1: implication of cyclin-dependent kinases. Biochem. Biophys. Res. Commun. 409, 187-192.
74. Leman, E. S., Magheli, A., Yong, K. M. A., Netto, G., Hinz, S. and Getzenberg, R. H. (2009). Identification of nuclear structural protein alterations associated with seminomas. J. Cell. Biochem. 108, 1274-1279.
75. Li, T., Inoue, A., Lahti, J. M. and Kidd, V. J. (2004). Failure to proliferate and mitotic arrest of CDK11(p110/p58)-null mutant mice at the blastocyst stage of embryonic cell development. Mol. Cell. Biol. 24, 3188-3197.
76. Li, Z. P., Jiao, X. M., Wang, C. G., Shirley, L. A., Elsaleh, H., Dahl, O., Wang, M., Soutoglou, E., Knudsen, E. S. and Pestell, R. G. (2010). Alternative cyclin D1 splice forms differentially regulate the DNA damage response. Cancer Res. 70, 8802-8811.
77. Li, H., Collado, M., Villasante, A., Matheu, A., Lynch, C. J., Canamero, M., Rizzoti, K., Carneiro, C., Martinez, G., Vidal, A. et al. (2012a). p27(Kip1) directly represses Sox2 during embryonic stem cell differentiation. Cell Stem Cell 11, 845-852.
78. Li, L., Wang, J., Hou, J., Wu, Z., Zhuang, Y., Lu, M., Zhang, Y., Zhou, X., Li, Z., Xiao, W. et al. (2012b). Cdk1 interplays with Oct4 to repress differentiation of embryonic stem cells into trophectoderm. FEBS Lett. 586, 4100-4107.
79. Lim, S. and Kaldis, P. (2012). Loss of Cdk2 and Cdk4 induces a switch from proliferation to differentiation in neural stem cells. Stem Cells 30, 1509-1520.
80. Liu, D., Matzuk, M. M., Sung, W. K., Guo, Q., Wang, P. and Wolgemuth, D. J. (1998). Cyclin A1 is required for meiosis in the male mouse. Nat. Genet. 20, 377-380.
81. Logan, C. Y. and Nusse, R. (2004). The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20, 781-810.
82. Loyer, P., Trembley, J. H., Lahti, J. M. and Kidd, V. J. (1998). The RNP protein, RNPS1, associates with specific isoforms of the p34cdc2-related PITSLRE protein kinase in vivo. J. Cell Sci. 111, 1495-1506.
83. Loyer, P., Trembley, J. H., Grenet, J. A., Busson, A., Corlu, A., Zhao, W., Kocak, M., Kidd, V. J. and Lahti, J. M. (2008). Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: influence of cyclin L isoforms on splice site selection. J. Biol. Chem. 283, 7721-7732.
84. Lu, X. Y., Liu, J. and Legerski, R. J. (2009). Cyclin E is stabilized in response to replication fork barriers leading to prolonged S phase arrest. J. Biol. Chem. 284, 35325-35337.
85. Major, M. L., Lepe, R. and Costa, R. H. (2004). Forkhead box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylationdependent recruitment of p300/CBP coactivators. Mol. Cell. Biol. 24, 2649-2661.
86. Malumbres, M. and Barbacid, M. (2009). Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 9, 153-166.
87. Malumbres, M., Sotillo, R., Santamaria, D., Galan, J., Cerezo, A., Ortega, S., Dubus, P. and Barbacid, M. (2004). Mammalian cells cycle without the Dtype cyclin-dependent kinases Cdk4 and Cdk6. Cell 118, 493-504.
88. Malumbres, M., Harlow, E., Hunt, T., Hunter, T., Lahti, J. M., Manning, G., Morgan, D. O., Tsai, L. H. and Wolgemuth, D. J. (2009). Cyclin-dependent kinases: a family portrait. Nat. Cell Biol. 11, 1275-1276.
89. Marais, A., Ji, Z., Child, E. S., Krause, E., Mann, D. J. and Sharrocks, A. D. (2010). Cell cycle-dependent regulation of the forkhead transcription factor FOXK2 by CDK·cyclin complexes. J. Biol. Chem. 285, 35728-35739.
90. Marques-Torrejon, M. A., Porlan, E., Banito, A., Gomez-Ibarlucea, E., Lopez-Contreras, A. J., Fernandez-Capetillo, O., Vidal, A., Gil, J., Torres, J. and Farinas, I. (2013). Cyclin-dependent kinase inhibitor p21 controls adult neural stem cell expansion by regulating Sox2 gene expression. Cell Stem Cell 12, 88-100.
91. Mikolcevic, P., Sigl, R., Rauch, V., Hess, M. W., Pfaller, K., Barisic, M., Pelliniemi, L. J., Boesl, M. and Geley, S. (2012). Cyclin-dependent kinase 16/PCTAIRE kinase 1 is activated by cyclin Y and is essential for spermatogenesis. Mol. Cell. Biol. 32, 868-879.
92. Morgan, D. O. (2007). The Cell Cycle: Principles of Control. London: New Science Press Ltd.
93. Myatt, S. S. and Lam, E. W. F. (2007). The emerging roles of forkhead box (Fox) proteins in cancer. Nat. Rev. Cancer 7, 847-859.
94. Nakayama, K. I. and Nakayama, K. (2006). Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 6, 369-381.
95. Nguyen, L., Besson, A., Heng, J. I., Schuurmans, C., Teboul, L., Parras, C., Philpott, A., Roberts, J. M. and Guillemot, F. (2006). p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev. 20, 1511-1524.
96. Niehrs, C. (2012). The complex world of WNT receptor signalling. Nat. Rev. Mol. Cell Biol. 13, 767-779.
97. Nigg, E. A. (1993). Cellular substrates of p34(cdc2) and its companion cyclindependent kinases. Trends Cell Biol. 3, 296-301.
98. Nurse, P. and Thuriaux, P. (1980). Regulatory genes controlling mitosis in the fission yeast Schizosaccharomyces pombe. Genetics 96, 627-637.
99. Nurse, P., Thuriaux, P. and Nasmyth, K. (1976). Genetic control of the cell division cycle in the fission yeast Schizosaccharomyces pombe. Mol. Gen. Genet. 146, 167-178.
100. Odajima, J., Wills, Z. P., Ndassa, Y. M., Terunuma, M., Kretschmannova, K., Deeb, T. Z., Geng, Y., Gawrzak, S., Quadros, I. M., Newman, J. et al. (2011). Cyclin E constrains Cdk5 activity to regulate synaptic plasticity and memory formation. Dev. Cell 21, 655-668.
101. Olmeda, D., Castel, S., Vilaro, S. and Cano, A. (2003). Beta-catenin regulation during the cell cycle: implications in G2/M and apoptosis. Mol. Biol. Cell 14, 2844-2860.
102. Orford, K., Orford, C. C. and Byers, S. W. (1999). Exogenous expression of betacatenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. J. Cell Biol. 146, 855-868.
103. Ortega, S., Prieto, I., Odajima, J., Martin, A., Dubus, P., Sotillo, R., Barbero, J. L., Malumbres, M. and Barbacid, M. (2003). Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat. Genet. 35, 25-31.
104. Ou, C.-Y., Poon, V. Y., Maeder, C. I., Watanabe, S., Lehrman, E. K., Fu, A. K. Y., Park, M., Fu, W.-Y., Jorgensen, E. M., Ip, N. Y. et al. (2010). Two cyclindependent kinase pathways are essential for polarized trafficking of presynaptic components. Cell 141, 846-858.
105. Park, H. J., Wang, Z., Costa, R. H., Tyner, A., Lau, L. F. and Raychaudhuri, P. (2008). An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycle. Oncogene 27, 1696-1704.
106. Park, M., Watanabe, S., Poon, V. Y., Ou, C.-Y., Jorgensen, E. M. and Shen, K. (2011). CYY-1/cyclin Y and CDK-5 differentially regulate synapse elimination and formation for rewiring neural circuits. Neuron 70, 742-757.
107. Patel, S. A. and Simon, M. C. (2010). Functional analysis of the Cdk7.cyclin H.Mat1 complex in mouse embryonic stem cells and embryos. J. Biol. Chem. 285, 15587-15598.
108. Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P. and Tsai, L. H. (1999). Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622.
109. Pavletich, N. P. (1999). Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J. Mol. Biol. 287, 821-828.
110. Peng, J., Zhu, Y., Milton, J. T. and Price, D. H. (1998). Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12, 755-762.
111. Pippa, R., Espinosa, L., Gundem, G., Garcia-Escudero, R., Dominguez, A., Orlando, S., Gallastegui, E., Saiz, C., Besson, A., Pujol, M. J. et al. (2012). p27Kip1 represses transcription by direct interaction with p130/E2F4 at the promoters of target genes. Oncogene 31, 4207-4220.
112. Rane, S. G., Dubus, P., Mettus, R. V., Galbreath, E. J., Boden, G., Reddy, E. P. and Barbacid, M. (1999). Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat. Genet. 22, 44-52.
113. Reed, S. I., Ferguson, J. and Groppe, J. C. (1982). Preliminary characterization of the transcriptional and translational products of the Saccharomyces cerevisiae cell division cycle gene CDC28. Mol. Cell. Biol. 2, 412-425.
114. Reynaud, E. G., Leibovitch, M. P., Tintignac, L. A. J., Pelpel, K., Guillier, M. and Leibovitch, S. A. (2000). Stabilization of MyoD by direct binding to p57(Kip2). J. Biol. Chem. 275, 18767-18776.
115. Rickert, P., Corden, J. L. and Lees, E. (1999). Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases. Oncogene 18, 1093-1102.
116. Russo, A. A., Jeffrey, P. D., Patten, A. K., Massague, J. and Pavletich, N. P. (1996). Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382, 325-331.
117. Sadasivam, S., Duan, S. and DeCaprio, J. A. (2012). The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression. Genes Dev. 26, 474-489.
118. Satyanarayana, A. and Kaldis, P. (2009). Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 28, 2925-2939.
119. Serizawa, H., Makela, T. P., Conaway, J. W., Conaway, R. C., Weinberg, R. A. and Young, R. A. (1995). Association of Cdk-activating kinase subunits with transcription factor TFIIH. Nature 374, 280-282.
120. Sherr, C. J. and Roberts, J. M. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512.
121. Shiekhattar, R., Mermelstein, F., Fisher, R. P., Drapkin, R., Dynlacht, B., Wessling, H. C., Morgan, D. O. and Reinberg, D. (1995). Cdk-activating kinase complex is a component of human transcription factor TFIIH. Nature 374, 283-287.
122. Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J. and Weinberg, R. A. (1995). Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82, 621-630.
123. Singh, A. M. and Dalton, S. (2009). The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell 5, 141-149.
124. Song, A., Wang, Q., Goebl, M. G. and Harrington, M. A. (1998). Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol. Cell. Biol. 18, 4994-4999.
125. Su, S. C. and Tsai, L. H. (2011). Cyclin-dependent kinases in brain development and disease. Annu. Rev. Cell Dev. Biol. 27, 465-491.
126. Tomashevski, A., Webster, D. R., Grammas, P., Gorospe, M. and Kruman, I. I. (2010). Cyclin-C-dependent cell-cycle entry is required for activation of nonhomologous end joining DNA repair in postmitotic neurons. Cell Death Differ. 17, 1189-1198.
127. Trembley, J. H., Hu, D. L., Hsu, L. C., Yeung, C. Y., Slaughter, C., Lahti, J. M. and Kidd, V. J. (2002). PITSLRE p110 protein kinases associate with transcription complexes and affect their activity. J. Biol. Chem. 277, 2589-2596.
128. Trimarchi, J. M. and Lees, J. A. (2002). Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 3, 11-20.
129. Tsutsui, T., Hesabi, B., Moons, D. S., Pandolfi, P. P., Hansel, K. S., Koff, A. and Kiyokawa, H. (1999). Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity. Mol. Cell. Biol. 19, 7011-7019.
130. Tudhope, S. J., Wang, C.-C., Petrie, J. L., Potts, L., Malcomson, F., Kieswich, J., Yaqoob, M. M., Arden, C., Hampson, L. J. and Agius, L. (2012). A novel mechanism for regulating hepatic glycogen synthesis involving serotonin and cyclin-dependent kinase-5. Diabetes 61, 49-60.
131. Wei, Y., Chen, Y. H., Li, L. Y., Lang, J., Yeh, S. P., Shi, B., Yang, C. C., Yang, J. Y., Lin, C. Y., Lai, C. C. et al. (2011). CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat. Cell Biol. 13, 87-94.
132. Weinberg, R. A. (1995). The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
133. Westerling, T., Kuuluvainen, E. and Makela, T. P. (2007). Cdk8 is essential for preimplantation mouse development. Mol. Cell. Biol. 27, 6177-6182.
134. Wong, A. S., Lee, R. H., Cheung, A. Y., Yeung, P. K., Chung, S. K., Cheung, Z. H. and Ip, N. Y. (2011). Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson's disease. Nat. Cell Biol. 13, 568-579.
135. Wonsey, D. R. and Follettie, M. T. (2005). Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res. 65, 5181-5189.
136. Wu, S. C. and Zhang, Y. (2011). Cyclin-dependent kinase 1 (CDK1)-mediated phosphorylation of enhancer of zeste 2 (Ezh2) regulates its stability. J. Biol. Chem. 286, 28511-28519.
137. Yu, D. S., Zhao, R. X., Hsu, E. L., Cayer, J., Ye, F., Guo, Y., Shyr, Y. and Cortez, D. (2010). Cyclin-dependent kinase 9-cyclin K functions in the replication stress response. EMBO Rep. 11, 876-882.
138. Yu, J.-H., Zhong, X.-Y., Zhang, W.-G., Wang, Z.-D., Dong, Q., Tai, S., Li, H. and Cui, Y.-F. (2012). CDK10 functions as a tumor suppressor gene and regulates survivability of biliary tract cancer cells. Oncol. Rep. 27, 1266-1276.
139. Zeng, X., Chen, S. and Huang, H. (2011). Phosphorylation of EZH2 by CDK1 and CDK2: a possible regulatory mechanism of transmission of the H3K27me3 epigenetic mark through cell divisions. Cell Cycle 10, 579-583.
140. Zhao, X., Feng, D., Wang, Q., Abdulla, A., Xie, X. J., Zhou, J., Sun, Y., Yang, E. S., Liu, L. P., Vaitheesvaran, B. et al. (2012). Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1. J. Clin. Invest. 122, 2417-2427.
141. Zhong, X. Y., Xu, X. X., Yu, J. H., Jiang, G. X., Yu, Y., Tai, S., Wang, Z. D. and Cui, Y. F. (2012). Clinical and biological significance of Cdk10 in hepatocellular carcinoma. Gene 498, 68-74.